2′‐Hydroxy‐4′′‐dimethylaminochalcone

The title compound, 3‐[4‐(di­methyl­amino)­phenyl]‐1‐(2‐hydroxy­phenyl)­prop‐2‐en‐1‐one, C₁₇H₁₇NO₂, is a chalcone derivative substituted by 2′‐hydroxyl and 4′′‐di­methyl­amino groups. The crystal structure indicates that the aniline and hydroxy­phenyl groups are nearly coplanar, with a dihedral angle of 10.32 (16)° between their phenyl rings. The molecular planarity of this substituted chalcone is strongly affected by the 2′‐hydroxyl group.     

(E)‐2‐(2‐Adamantylidene)‐3‐(1‐ferrocenylethylidene)succinic anhydride

The title compound, [Fe(C₅H₅)(C₂₁H₂₁O₃)], was obtained from successive Stobbe condensations between ketones and di­methyl succinate. The succinic anhydride five‐membered ring is distorted significantly from planarity, with the buta­diene moiety being twisted by 49.3 (2)° from planarity and the C atoms at the succinic anhydride end of the alkene bonds showing significant pyramidalization. The cyclo­penta­diene rings of the ferrocenyl moiety adopt an almost eclipsed conformation.     

1‐[4‐(Methyl­sulfonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole derivatives

Three related compounds containing a pyrazole moiety with vicinal phenyl rings featuring a methyl­sulfonyl substituent are described, namely 3‐methyl‐1‐[4‐(methyl­sulfonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole, C₁₇H₁₆N₂O₂S, ethyl 1‐[4‐(methyl­sul­fonyl)­phenyl]‐5‐phenyl‐1H‐pyrazole‐3‐carboxyl­ate, C₁₉H₁₈N₂O₄S, and 1‐[4‐(methyl­sulfonyl)­phenyl]‐3‐[3‐(morpholino)­phenoxy­methyl]‐5‐phenyl‐1H‐pyrazole, C₂₇H₂₇N₃O₄S. The design of these compounds was based on celecoxib, a selective cyclo­oxy­genase‐2 (COX‐2) inhibitor, in order to study the influence of various substituents on COX‐2 and 5‐lipoxy­genase (5‐LOX) inhibition.     

4‐[N,N‐Bis(2‐hydroxy­imino‐2‐phenyl­ethyl)­amino]‐1,5‐di­methyl‐2‐phenyl‐2,3‐di­hydro‐1H‐pyrazol‐3‐one monohydrate

The title compound, C₂₇H₂₇N₅O₃·H₂O, is built up from pyrazolinone, phenyl and aceto­phenone oxime moieties. The 2‐­phenyl substituent is nearly perpendicular to the pyrazo­linone ring, with a dihedral angle of 87.66 (1)°. The aceto­phenone oxime moieties are twisted out of the pyrazolinone‐ring plane by 47.04 (1)°. The mol­ecules in the crystal pack in an antiparallel fashion and are held together by hydrogen‐bonded water mol­ecules and intermolecular O—H⋯O and O—H⋯N hydrogen bonds.     

(Z)‐7‐Chloro‐3‐[(3‐chloro­phenyl)­methyl­idene]‐4‐p‐tosyl‐3,4‐di­hydro‐2H‐1,4‐benzoxazine

In the title compound, C₂₂H₁₇Cl₂NO₃S, the mol­ecule is a substituted 3,4‐di­hydro‐2H‐1,4‐benzoxazine compound which has three phenyl rings which are essentially planar. The 3,4‐di­hydro‐2H‐oxazine part of the mol­ecule is fused to the benzo ring and has a half‐boat conformation; the dihedral angle between the planar part of the oxazine ring and the benzo ring is 10.2 (2)°. The (3‐chloro­phenyl)­methyl­idene substituent has a Z configuration in relation to the ring N atom of the oxazine moiety. Interestingly, the p‐toluenesulfonyl (p‐tosyl) substituent on the ring N atom protrudes away from the 3‐­chloro­phenyl substituent thus avoiding any steric interaction.     

Two 5‐oxa‐2,6‐diazaspiro[3.4]octan‐1‐one derivatives from the [3+2] cyclo­addition of methylenelactams with nitrones

The two title 5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one adducts, 7‐benzoyl‐2‐(4‐methoxy­phenyl)‐6‐phenyl‐5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one, C₂₅H₂₂N₂O₄, (III), and 6‐tert‐butyl‐2‐(4‐methyl­phenyl)‐7‐phenyl‐5‐oxa‐2,6‐di­aza­spiro­[3.4]­octan‐1‐one, C₂₂H₂₆N₂O₂, (IV), were obtained from a stereospecific [3+2] 1,3‐cyclo­addition of 3‐methyl­ene azetidin‐2‐ones as dipolaro­philes with nitro­nes. The lactam ring is conjugated with the p‐­methoxy­phenyl or p‐methyl­phenyl moiety. The envelope conformations of the isoxazolidine rings in (III) and (IV) are different, leading the substituents to be pseudo‐axial in (III) and pseudo‐equatorial in (IV).     

Bis(2,5‐dimethoxy‐4‐methylphenyl)methane and bis(2,5‐dimethoxy‐3,4,6‐trimethylphenyl)methane

Bis(2,5‐di­methoxy‐4‐methyl­phenyl)­methane, C₁₉H₂₄O₄, (IIa), was obtained and characterized as a minor product from the reaction of tolu­hydro­quinone di­methyl ether (1,4‐dimethoxy‐2‐methylbenzene) with N‐(hydroxy­methyl)­tri­fluoro­acet­amide. Similarly, bis(2,5‐di­methoxy‐3,4,6‐tri­methyl­phenyl)­methane, C₂₃H₃₂O₄, (IIb), was prepared from the corresponding reaction of tri­methyl­hydro­quinone di­methyl ether (2,5‐dimethoxy‐1,3,4‐trimethylbenzene). The mol­ecules of (IIa) and (IIb) each lie on a twofold axis passing through the methyl­ene group. The dihedral angle between the planar phenyl rings is 73.4 (1)° in (IIa) and 77.9 (1)° in (IIb). The external bond angles around the bridging methyl­ene group are 116.6 (2) and 117.3 (2)° for (IIa) and (IIb), respectively. In (IIa), the methoxy substituents lie in the plane of the ring and are conjugated with the aromatic system, whereas in (IIb), they are almost perpendicular to the phenyl ring and are positioned on opposite sides.     

1‐{5‐[2‐(Tri­fluoro­methyl)­phenyl]‐1,3,4‐thia­diazol‐2‐yl}guanidinium chloride

In the title compound, C₁₀H₉F₃N₅S⁺·Cl^?, which was developed as a potential anticonvulsant, the phenyl ring, the thia­diazo­le ring and the guanidinium moiety are all planar. There is a dihedral angle of 48.9 (1)° between the thia­diazole and phenyl rings which prevents steric hindrance arising from the π bonds within the former, and the tri­fluoro­phenyl moiety attached to the latter. The thia­diazole and guanidinium moieties are twisted by 12.7 (2)° with respect to each other. An extensive network of hydrogen bonds, predominantly involving the chloride ion, maintains the crystal structure.     

Ethyl β‐{2‐[4‐(dimethylamino)phenyliminomethyl]‐1‐(phenylsulfonyl)indol‐3‐yl}acrylate

The title compound, C₂₈H₂₇N₃O₄S, crystallizes in the centrosymmetric space group P2₁/n, with one mol­ecule in the asymmetric unit. In the indole ring, the dihedral angle between the fused rings is 3.6 (1)°. The phenyl ring of the sulfonyl substituent makes a dihedral angle of 79.2 (1)° with the best plane of the indole moiety. The phenyl ring of the di­methyl­amino­phenyl group is orthogonal to the phenyl ring of the phenyl­sulfonyl group. The dihedral angle formed by the weighted least‐squares planes through the pyrrole ring and the phenyl ring of the di­methyl­amino­phenyl group is 7.8 (1)°. The molecular structure is stabilized by C—H?O and C—H?N interactions.     

11‐Methyl‐12a‐phenyl‐9a,12a‐di­hydro­phenanthro­[9′,10:5,6][1,4]­dioxino­[2,3‐d]­thia­zole

In the title compound, C₂₄H₁₇NO₂S, the dioxine and thia­zoline rings are distorted from planarity towards a half‐chair and an envelope conformation, respectively. The configurations of the dioxine ring, the thiazoline ring and the attached phenyl ring are conditioned by the sp³ state of the two bridgehead C atoms. The phenanthrene system is nearly coplanar with the dioxine ring, while the attached phenyl ring is orthogonal to the thia­zoline ring.     

1,3‐Dimethyl‐2‐oxo‐4,6‐diphenyl‐1,2,3,4‐tetrahydropyridine‐3‐carbonitrile

The crystal structure of the title compound, C₂₀H₁₈N₂O, reveals a distorted half‐chair conformation of the central tetra­hydro­pyridine (THP) ring, with the cyano‐ and adjacent phenyl‐substituted C atoms displaced by 0.329 (1) and ?0.315 (1) Å, respectively, from the THP best plane. Steric interactions force the phenyl rings out of the THP plane by 49.21 (9) and 65.76 (5)°. The cyano moiety is coplanar with the THP plane.     

Di­propyl 3,6‐di­phenyl‐1,2‐di­hydro‐1,2,4,5‐tetrazine‐1,2‐di­carboxyl­ate

The title compound, C₂₂H₂₄N₄O₄, was prepared from propyl chloro­formate and 3,6‐di­phenyl‐1,2‐di­hydro‐s‐tetrazine. This reaction yields the title compound rather than di­propyl 3,6‐di­phenyl‐1,4‐di­hydro‐s‐tetrazine‐1,4‐di­carboxyl­ate. The 2,3‐di­aza­buta­diene group in the central six‐membered ring is not planar; the C=N double‐bond length is 1.285 (2) Å, and the average N—N single‐bond length is 1.401 (3) Å, indicating a lack of conjugation. The ring has a twist conformation, in which adjacent N atoms lie 0.3268 (17) Å from the plane of the ring. The mol­ecule has twofold crystallographic symmetry.     

Absolute configuration of (−)‐4‐(3,4‐di­chloro­phenyl)‐4‐(2‐pyridyl)­butanoic acid: essential information to determine crucial steric features of ­arpromidine‐type hist­amine H2 receptor agonists

The structural information gained from the study of the chiral building block (R)‐(?)‐4‐(3,4‐di­chloro­phenyl)‐4‐(2‐pyridyl)­butanoic acid–l ‐(?)‐ephedrine [methyl(1‐hydroxy‐1‐phenyl­prop‐2‐yl)ammon­ium 4‐(3,4‐di­chloro­phenyl)‐4‐(2‐pyrid­yl)but­an­oate], C₁₀H₁₆NO⁺·C₁₅H₁₂Cl₂NO₂^?, can be used to deduce the absolute configuration of highly potent arpromidine‐type hist­amine H₂ receptor agonists, as the chiral butanoic acid can be converted to (R)‐(?)‐3‐(3,4‐di­chloro­phenyl)‐3‐(2‐pyridyl)­propyl­amine and to the corresponding R‐configured arpromidine analogue.     

1‐Acetyl‐3′‐(4‐bromophenyl)‐3′‐chlorospiro[3H‐indole‐3,2′‐oxetan]‐2(1H)‐one

In the title compound, C₁₈H₁₃BrClNO₃, the heterocyclic ring of the indole is distorted from planarity towards an envelope conformation. The orientations of the indole, oxetane, chloro and bromo­phenyl substituents are conditioned by the sp³ states of the spiro‐junction and the Cl‐attached C atoms.     

4‐(4‐Fluoro‐3‐phenoxy­phen­yl)‐6‐(4‐fluoro­phen­yl)‐2‐oxo‐1,2‐dihydro­pyridine‐3‐carbonitrile and the 6‐(4‐methyl­phen­yl)‐ analogue

The crystal structures of the title compounds, viz. C₂₄H₁₄F₂N₂O₂, (I), and C₂₅H₁₇FN₂O₂, (II), respectively, have been determined in order to unravel the role of an ordered F atom in generating stable supra­molecular assemblies. On changing the substitution from fluorine to a methyl group, C—H⋯F inter­actions are replaced by C—H⋯π inter­actions, revealing the importance of such weak inter­actions when present alongside N—H⋯O and C—H⋯O hydrogen bonds. The dihedral angle between the planes of the 4‐fluoro­phenyl ring and the pyridine ring is 26.8 (1)° in (I), while that between the planes of the 4‐methyl­phenyl and pyridine rings is 29.5 (1)° in (II).     

(η6‐Bi­phenyl)­tri­carbonyl­chromium and μ‐(η6:η6)‐bi­phenyl‐bis­(tricarbonyl­chromium)

The title compounds, [Cr(C₁₂H₁₀)(CO)₃] and [Cr₂(C₁₂H₁₀)(CO)₆], serve as a fundamental standard of comparison for other mono‐ and polysubstituted (η⁶‐bi­phenyl)­tri­carbonyl­chromium compounds. (η⁶‐Bi­phenyl)­tri­carbonyl­chromium has a typical piano‐stool coordination about the Cr center, and the dihedral angle between the planes of the phenyl rings is 23.55 (5)°. The corresponding angle in μ‐(η⁶:η⁶)‐bi­phenyl‐bis­(tri­carbonyl­chromium) is 0° because the mol­ecule occupies a crystallographic inversion center; the Cr atoms reside on opposite sides of the bi­phenyl ligand. Density functional theory and natural bonding orbital theory analyses were used to scrutinize the geometry of these and closely related compounds to explain important structural features.     

5‐Acetyl‐2‐amino‐6‐methyl‐4‐(3‐nitrophenyl)‐4H‐pyran‐3‐carbonitrile and 2‐amino‐5‐ethoxycarbonyl‐6‐methyl‐4‐(3‐nitrophenyl)‐4H‐pyrano‐3‐carbonitrile

The structures of the title compounds, C₁₅H₁₃N₃O₄, (I), and C₁₆H₁₅N₃O₅ [IUPAC name: ethyl 6‐amino‐5‐cyano‐2‐methyl‐4‐(3‐nitro­phenyl)‐4H‐pyrano‐3‐carboxyl­ate], (II), are very similar, with the heterocyclic rings adopting boat conformations. The pseudo‐axial m‐nitro­phenyl substituents are rotated by 84.0 (1) and 98.7 (1)° in (I) and (II), respectively, with respect to the four coplanar atoms of the boat. The dihedral angles between the phenyl rings and nitro groups are 12.1 (2) and 8.4 (2)° in (I) and (II), respectively. The two compounds have similar patterns of intermolecular N—H?O and N—H?N hydrogen bonding, which link mol­ecules into infinite tapes along b .     

[2‐(Isopropylthio)benzoato‐O,S]phenyl(triphenylphosphine)palladium(II) tetrahydrofuran solvate

In the title compound, [Pd(C₆H₅)(C₁₀H₁₁O₂S)(C₁₈H₁₅P)]·C₄H₈O, an iso­propyl­thio­benzoate ligand is coordinated in a bidentate fashion to the central Pd atom through the O and S atoms. The square‐planar geometry of the Pd atom is completed by a phenyl ligand and a tri­phenyl­phosphine group but is distorted by the bidentate ligand, which forms a six‐membered chelate ring. This ring deviates strongly from planarity, which is illustrated by the plane through the phenyl portion of the chelate ring forming a dihedral angle of 62.3 (1)° with the coordination plane.     

4‐[4‐(Di­methyl­amino)­benzyl­idene­amino]‐3,5‐bis(2‐pyridyl)‐4H‐1,2,4‐triazole

The title compound, C₂₁H₁₉N₇, is a poly­pyridine ligand that is suitable for assembling complex metal systems capable of photoinduced electron transfer. The solid‐state structure has been determined at room temperature by single‐crystal X‐ray diffraction. The mol­ecule is not flat and both the bis­(pyridyl)­triazole and the benzyl­id­ene­amine fragments show significant distortions from planarity.     

3,5‐Di­amino‐6‐(2‐fluoro­phenyl)‐1,2,4‐triazine–di­methyl­form­amide (1/1)

The title compound, C₉H₈FN₅·C₃H₇NO, contains two independent complexes in the asymmetric unit, each consisting of one 3,5‐di­amino‐6‐(2‐fluoro­phenyl)‐1,2,4‐triazine mol­ecule and one di­methyl­form­amide solvent mol­ecule. One triazine mol­ecule is disordered over two conformations within the crystal, the occupancies being 62 (1) and 38 (1)%. The phenyl ring of this mol­ecule resolves into two conformations rotated by almost 180° about the bridging bond between the two rings, while the triazine rings approximately superimpose on each other. The triazine mol­ecules of the asymmetric unit differ in the dihedral angles between their respective phenyl and triazine ring planes, these being 57.6 (2)° for the fully occupied, and 76.9 (6) and 106.8 (8)° for the partially occupied mol­ecules. An extensive network of hydrogen bonds maintains the crystal structure.